Introduction
Control of cellular proliferation and dierentiation is paramount for normal cellular function and tissue homeostasis. Alterations in the control of cellular proliferation and dierentiation is believed to be an important change which occurs during neoplastic progression (Hennings et al., 1993; Rubin, 1993; Sell and Pierce, 1994; Williams et al., 1992) . In this regard, neoplastically transformed stem cells are no longer responsive to external dierentiation signals, but instead proliferate without concomitant dierentiation (Hennings et al., 1993; Sell and Pierce, 1994) . Mutation of genes which control cellular dierentiation have been described in several tumor types, with alterations in dierentiation controlling genes in hematopoietic cells being the best characterized (Sawyer et al., 1991) . In these systems, reestablishment of dierentiation control by replacement of the defective gene results in external dierentiation signal-sensitive terminal differentiation of the neoplastic cell (Hennings et al., 1993; Sawyers et al., 1991; Sell and Pierce, 1994) . In the liver, the stem cells which gives rise to partially and completely dierentiated epithelial cells, including hepatocytes and ductal epithelial, are known as oval cells (Aterman, 1992; Brill et al., 1993; Coleman et al., 1993; Fausto, 1990; Marceau et al., 1989; Sell, 1993; Thorgeirsson, 1993) . Oval cells are hypothesized to be the cell type which undergoes neoplastic transformation and which gives rise to multiple liver tumor types including hepatocellular carcinomas, ductal carcinomas and undierentiated carcinomas (Aterman, 1992; Brill et al., 1993; Coleman et al., 1993; Factor et al., 1994; Fausto, 1990; Marceau et al., 1989; Sell, 1993; Thorgeirsson, 1993) . This gene which when mutated results in a block in oval cell dierentiation, the initiating mutation in liver neoplasia, has not yet been identi®ed.
The Tg737 gene was originally identi®ed by insertional mutagenesis and positional cloning as the gene which is altered in autosomal recessive polycystic kidney disease in the TgN737Rpw transgenic mouse line developed in the laboratory of Dr Richard Woychik at Oak Ridge National Laboratories (Moyer et al., 1994; Schrick et al., 1995; Richards et al., 1996 Richards et al., , 1997 . The Tg737 gene encodes a 824 amino acid protein which contains 10 tetratricopeptide repeat sequences, a protein motif found in multiple genes including several which function to control cellular proliferation and sporulation in the ®ssion yeast Schizosaccharomyces pombe Goeble and Yanagida, 1991; Hirano et al., 1990; Kumada et al., 1995; Moyer et al., 1994; Schrick et al., 1995; Sikorski et al., 1993) . In the initial description of the polycystic kidney disease associated with Tg737 gene mutation, additional organ alterations were observed including biliary dysplasia in the liver, an observation which was interpreted as liver stem cell (oval cell) hyperplasia (Moyer et al., 1994; Richards et al., 1996 Richards et al., , 1997 Schrick et al., 1995) . This observation prompted us to investigate the role of the Tg737 gene in neoplasia of the liver since aberrant cellular proliferation is believed to play an important role in neoplasia (Cohen and Ellwein, 1990; Hennings et al., 1993; Sell and Pierce, 1994) . The results of these investigations are presented in this report.
Results

Analysis of alteration of the Tg737 gene in tumors and tumorigenic cell lines
Tg737 gene integrity was analysed in rodent and human liver tumors and human tumorigenic cell lines. As can be seen in Figure 1a , analysis of hepatocellular carcinomas induced in the rat by various carcinogenic chemicals including the genotoxic carcinogens a¯atoxin B1, diethylnitrosamine, and acetylamino¯uorene (AAF) and the nongenotoxic carcinogen Wyeth 14,643 demonstrated that the Tg737 gene is altered by either gene deletion or rearrangement in 40% of the liver neoplasia investigated. Importantly, in these tumors alteration of the retinoblastoma gene, a gene closely linked chromosomally to the Tg737 gene, was not found (data not shown). Figure 1b demonstrates that the Tg737 gene is altered, via speci®c exon deletions, in 4/11 human liver tumors analysed. Speci®c exon deletions, including exons 3, 5, 14 and 22 of the Tg737 gene were observed, with the remaining exons intact. No alteration of the surrounding normal tissue was observed, Finally, analysis of human liver, kidney, pancreatic and human breast tumor cell lines indicates that the Tg737 gene is grossly altered in liver, kidney and pancreatic tumor cell lines but not human breast tumor cell lines, while the RB1 gene, showed no sign of alteration ( Figure 1c) . Together these data demonstrate gross alteration of the Tg737 gene in a variety of rodent and human liver tumors and tumor cell lines indicating a potential role for the Tg737 gene in the formation of multiple tumor types.
Tumor suppression potential of the Tg737 gene
Observation of Tg737 gene alterations in liver neoplasia prompted us to investigate the role of Tg737 gene plays in the neoplastic process. In order to address this question, a Tg737 expression vector was constructed, transfected into the HL617-1T1 cell line, and cell lines with stable Tg737 gene expression established. The HL617-1T1 mouse oval cell line is a tumorigenic segregant of the HL617-1 mouse oval cell line, a cell line derived from the liver of an insertionally inactivated and functionally deleted Tg737 transgenic mouse (Richards et al., 1996 (Richards et al., , 1997 . Vector containing cells were selected by growth in the presence of toxic levels of neomycin, clonally isolated, propagated, and checked for Tg737 gene expression by Northern blot analysis (Figure 2a) . Three Tg737 expressing cell lines were isolated, including a high level Tg737 expressing cell line (HL617-1TITg2), a moderate level Tg737 expressing cell line (HL617-1T1Tg2/2), and a low level Tg737 Richards et al., 1996 Richards et al., , 1997 . The cell line containing the control vector (HL617-1T1N2) did not express Tg737 mRNA (Figure 2a ), Similar to the parental cell line HL617T1 (Richards et al., 1996 (Richards et al., , 1997 . As can be seen in Figure 2b , low and moderate level expression of the Tg737 gene did not signi®cantly alter the cell culture growth of the HL617-1T1Tg5 and HL617-1T1Tg2/2 cell lines relative to the vector control (HL617-1T1N2) and parental (HL617-1T1) cell lines, although very high level expression of the Tg737 gene did slow cell growth (HL617-1T1Tg2). Interestingly, revertants of the HL617-1T1Tg2 cell line which have lost expression of the Tg737 gene demonstrated a growth rate which was similar to the vector control, indicating that the high Tg737 expression level was responsible for the reduced growth rate (data not shown). Tumorigenicity analysis in nude mice of the Tg737 expressing cell lines indicate that tumorigenicity of two of these cell lines (HL617-1T1Tg2 and HL617-1T1Tg2/2) was completely suppressed relative to the tumorigenicity of vector control cell line (HL617-1T1N2) while tumorigenic growth of the low level Tg737 expressing cell line (HL617-1T1Tg5) was reduced in terms of both time to tumor and tumor size relative to vector control cell line (Figure 2c ). In support of the Tg737 gene as a tumor suppressor gene, mice which were either homozygous normal (two normal alleles) or heterozygous deleted (one normal allele and one insertionally inactivated allele) at the Tg737 locus were treated with the carcinogen diethylnitrosamine (DEN) and carcinogen-induced foci were compared in the two groups. As demonstrated in Figure 3 , mice which were heterozygous deleted at the Tg737 locus demonstrated a fourfold increase in the percent of liver occupied by preneoplastic foci induced by DEN. These data indicate that, similar to other tumor suppressor genes, loss of The cells were cultured in either 100 ng/ml epidermal growth factor (EGF), 100 ng/ml epidermal growth factor and 10 ng/ml transforming growth factor beta (EGF+TGF-b), or 10 ng/ml transforming growth factor beta (TGF-b). All photographs made at the 106magni®cation (Figure 4a ). This observation con®rmed our previous ®nding that the oval cell hyperplasia observed in the TgN737Rpw transgenic mice demonstrating that oval cells in the liver of the homozygous mutant Tg737 mice were proliferating without concommitant differentiation (Richards et al., 1996 (Richards et al., , 1997 . Second, ectopic reexpression of the Tg737 gene in Tg737 lacking tumorigenic oval cells results in an increase in multinucleated cells (Figure 4b ). This observation indicates that the Tg737 gene may function not only in nuclear division (mitosis), presumably at the G1 phase of the cell cycle when proliferation/dierentiation determination occurs, but may also function to control cytoplasmic cell division (cytokinesis). Finally, reexpression of the Tg737 gene in Tg737 lacking tumorigenic oval cells results in the reestablishment of responsiveness to outside dierentiation factor stimulation. As shown in Figure 4c , HL617-1T1 cells do not respond to a combination of epidermal growth factor (EGF) and transforming growth factor-b1 (TGF-b1) by displaying a cell scattering phenotype, a response which we have demonstrated to occur in oval cells and which serves as a short-term surrogate marker for oval cell dierentiation (Isfort et al., 1997; R Isfort, manuscript in preparation) . Cellular scattering is the initial step in a multistep process which ultimately leads to cellular dierentiation in multiple cell types including oval cells (Birchmeier and Birchmeier, 1994; Caulin et al., 1995; Franch et al., 1995; Isfort et al., 1997b; Nickolo et al., 1988; Rijksen et al., 1993) . HL617-1T1 cells which reexpress the Tg737 gene reacquire the cellular scattering phenotype in response to stimulation with a combination of EGF and TGF-b1, indicating that Tg737 gene expression is indeed necessary for dierentiation factor signaling ( Figure 4c ).
Discussion
In this report we present evidence that the Tg737 gene may play a role in tumor formation since the gene is found altered in liver tumors and liver, pancreatic and kidney tumorigenic cell lines and functions as a tumor suppressor gene when reintroduced into Tg737 lacking tumorigenic cells. We believe this is the ®rst report of a tetratrico peptide repeat (TPR) family member playing role in neoplastic transformation. The TPR family of genes consist of multiple members including genes which have been implicated to function in mitosis, transcriptional control, splicing, and protein import (Goeble and Yanagida, 1991) . While the biology of the TPR family of genes is best understood in yeast, mammalian members of the TPR gene family are currently being identi®ed and their roles in biological roles characterized Goeble and Yanagida, 1991) . The observations on Tg737 function presented in this report are similar to what has been observed with other tetratrico peptide repeat gene family members which function to control cellular proliferation and dierentiation in the ®ssion yeast S. pombe (Kumada et al., 1995) . For example the nuc2 gene functions in S. pombe to control proliferation/dierentiation in response to external signals such as nitrogen starvation, by blocking mitosis at the G1 checkpoint. In S. pombe mutation of the nuc2 gene results in a phenotype characterized by cells which no longer respond to external dierentiation signals by halting mitosis in G1 but instead undergo continuous mitosis. We believe the nuc2 gene, while not the S. pombe homologue of the Tg737 gene, performs an analogous function to the mammalian Tg737 gene in regards to the role which the Tg737 gene plays in controlling cellular proliferation/dierentiation in oval cells for the following reasons. First, mutation of the Tg737 gene results in a phenotype in which liver stem cells no longer respond to external dierentiation signals by halting mitosis at the G1 checkpoint and undergo dierentiation. Instead the liver stem cells proliferate without concomitant dierentiation. Reintroduction of the Tg737 gene into liver stem cells results in the reestablishment of the dierentiation signaling mechanism since the cells once again become responsive to the EGF+TGF-b differentiation signal. This situation is similar to that observed in S. pombe following nuc2 deletion and reintroduction. Second, ectopic expression of the nuc2 gene in S. pombe results in inappropriate expression of the nuc2 gene during the cell cycle, giving rise to cells which undergo mitosis without concomitant cytokinesis, i.e. multinucleated cells (Kumada et al., 1995) . In an analogous manner, ectopic expression of the Tg737 gene in oval cells results in multinucleated cells. Therefore, the Tg737 gene appears to function in a manner similar to other members of the tetratricopeptide repeat gene family to control cellular differentiation and proliferation in two ways, during mitosis probably by acting at the G1 checkpoint and during cytokinesis by controlling cytoplasmic division following nuclear division. The observations on the function of the Tg737 gene in liver stem cells provides insight into the biology of the phenotypes observed in autosomal recessive polycystic kidney disease (ARPKD) (Avner, 1994a,b) . In ARPKD, cystic growth in both the kidney and liver results from proliferation of stem cells, known as`oval cells' in the liver and`primary cells' in the kidney. Therefore, the observation that loss of Tg737 gene function leads to ARPKD can be explained by alteration in stem cell growth and dierentiation via loss of dierentiation responsiveness resulting in uncontrolled stem cell proliferation without concomitant dierentiation.
In conclusion, the Tg737 gene is altered in liver neoplasia and functions as a tumor suppressor gene which functions to control stem cell proliferation/ dierentiation in at least three tissues ± liver, pancreas and kidney. In addition the ®nding of alterations of a gene which controls liver stem cell (oval cell) proliferation/dierentiation argues for the importance of the liver stem cell in the neoplastic process and more importantly, the role of a block in dierentiation as an important and early alteration during liver tumorigenesis.
Materials and methods
Analysis of the status of the Tg737 gene in human and rodent liver tumors and tumorigenic cell lines Rat liver tumor induction by the indicated carcinogens was as described previously (Lilleberg et al., 1992a,b . DNA from tumorous and nontumorous tissue and/or cells was isolated, digested with restriction enzymes (EcoRI, BamHI, HindIII), separated by agarose gel electrophoresis, Southern blotted, duplicate blots probed with either a nick translated 32 P-labeled Tg737 gene probe (Moyer et al., 1994) or a 32 P-labeled RB1 gene probe (ATCC#65002), and hybridized probes visualized by autoradiography, all as described previously (Isfort et al., 1987 (Isfort et al., , 1995 . Tumorigenic cell line cells (HepG2 -ATCCHB8065, SKHepI -ATCCHTB52, Caki-1 -ATCCHTB46, SW839 -ATCCHTB49, Capan-2 ATCCHTB80, BxPC-3 -ATCCCRL1687, PANC-1 -ATCCCRL1469, BT-549 -ATCCHTB122, DU4475 -ATCCHTB123, Hs578T -ATCCHTB126, MDA-MB-415 -ATCCHTB128, MDA-MB-435S -ATCCHTB129, MDA-MB-436-ATCCHTB130, MDA-MB-453 -ATCCHTB131, MDA-MB-468 -ATCCHTB132, T -47D -ATCCHTB133) were cultured in DMEM/F12 medium containing 10% fetal bovine serum (FBS) in a cell culture incubator kept at 378C, 5% carbon dioxide, and 95% relative humidity. DNA was isolated and analysed from the cell lines as described above. PCR analysis of the human Tg737 gene was performed as described previously (Schrick et al., 1995) . Normal and tumorous liver DNA was kindly provided by Dr Randy Jirtle, Duke University.
Analysis of the tumor suppressing potential of the Tg737 gene in a mouse liver tumorigenic cell line The pBAP737-neo vector was constructed by removal of the human b actin-Tg737 cDNA-SV40 polyA fragment (containing position 1 ± 2545 and 5' untranslated region of the Tg737 cDNA) by ClaI digestion from the vector pBAP737 (Moyer et al., 1994) and placed into the ClaI site of the pPGK-neo vector (Soriano et al., 1991) . Expression of the Tg737 gene was accomplished by introducing the pBAP737-neo and pPGK-neo control vector into the HL617-1T1 mouse oval cell line (Richards et al., 1996 (Richards et al., , 1997 utilizing Lipofectamine technology (GIBCO/BRL).
Vector containing cells were selected for neomycin resistance in 500 mg/ml neomycin containing media. Neomycin resistant cells were assayed for Tg737 expression by Northern blot analysis. RNA was isolated from the indicated cell line using RNAzol technology (Cinna/ Biotecx) according to the manufacturer's recommendations. Total cellular RNA was separated by denaturing agarose gel electrophoresis. Northern blotted, Tg737 mRNA identi®ed by 32 P-labeled probe hybridization and quantitated by autoradiographic analysis as described previously (Isfort et al., 1994) . Growth of the Tg737 expressing and nonexpressing cell lines was measured by direct cell counts utilizing Coulter counting technology as described previously (LeBoeuf and Kerckaert, 1986) . All measurements were performed in duplicate. Nude mouse tumorigenicity analysis was performed by subcutaneous injection of 10 6 cells/0.1 ml into the¯anks and midshoulders of nude mice as described previously (Isfort et al., 1997a) .
Comparison of carcinogen-induced preneoplastic foci induction in Tg737 homozygous normal and heterozygous deleted mice Male 15 day old C3H mice, congenic for the TgN737 Rpw insertional mutation, which were either homozygous normal or heterozygous deleted at the Tg737 locus were treated once by subcutaneous injection with 5 mg/kg DEN (Sigma). Foci size measurements were made 24 weeks following DEN treatment utilizing a BioQuant morphometrics imaging system as described previously (Pugh and Goldfarb, 1992) .
Analysis of the function of the Tg737 gene
Liver specimens from FVB mice which are either wild-type, heterozygous, or homozygous for mutations at the Tg737 locus were ®xed in neutral buered formalin, embedded in paran, sections prepared and subjected to hemotoxylin and eosin staining as has been described previously (Moyer et al., 1994) . Cells either lacking a functional Tg737 gene (HL617-1T1 N2) or ectopically expressing the Tg737 gene (HL617-1T1 Tg2/2) were cultured in DMEM/F12 medium containing 10% fetal bovine serum and photographed using a Nikon Diaphot 300 microscope ®tted with a standard phase contrast optical system. Tg737 lacking mouse oval cell line (HL617-1T1) and Tg737 expressing variant of this cell line (HL617-1T1 Tg5) were cultured in DMEM/F12 containing 10% fetal bovine serum, serum starved for 8 h, exposed overnight to either 100 ng/ml EGF, 100 ng/ml EGF+10 ng/ml TGF-b, or 10 ng/ml TGF-b, and examined for cell scattering. Cells were photographed utilizing Homan modulation contrast optics.
